Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Nature Biomedical Engineering|March 14, 2020
Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and oesophageal epithelial cancersSusanne Kossatz, Giacomo Pirovano, Paula Demétrio De Souza França, et al.
Blood Advances|February 5, 2025
Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignanciesSanam Shahid, Susan E Prockop, Georgia C Flynn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2023
Combination Early-Phase Trials of Anticancer Agents in Children and AdolescentsLucas Moreno, Steven G DuBois, Julia Glade Bender, et al.
Blood Advances|November 17, 2021
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantationMadhavi Lakkaraja, Michael Scordo, Audrey Mauguen, et al.
Neuro-Oncology|April 9, 2022
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade gliomaTom Rosenberg, Kee Kiat Yeo, Audrey Mauguen, et al.
Cancer Discovery|March 17, 2019
Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel AKT1 Fusion-Driven CancerEmily K Slotkin, Daniel Diolaiti, Neerav N Shukla, et al.
The Journal of Clinical Investigation|March 23, 2023
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplantSusan E Prockop, Aisha Hasan, Ekaterina Doubrovina, et al.
Leukemia & Lymphoma|April 2, 2020
The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patientsRichard J Lin, Laure Michaud, Stephanie M Lobaugh, et al.
Pageof 13